Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) (TX) Price & Performance

Maravai LifeSciences Holdings Inc. Class A Common StockTrade
Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value)Trade

Price performance (Past 24H)

Key statistics

Maravai LifeSciences Holdings Inc. Class A Common Stock vs Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) trades at $58.55 (market cap $11.58B). The key difference: Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) is far larger — about 11.9× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) pays a 3.73% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value) for 0 Days on average.

MRVITX
Market Cap
$972.90M$11.58B
Volume
4,325,710456,367
Sector
HealthBasic Materials
52-Week High
$9.00$58.99
52-Week Low
$2.83$35.26
Typical Hold Time
0 Days0 Days
Enterprise Value
$1.08B$11.90B
Dividend Yield
—3.73%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Maravai LifeSciences Holdings Inc. Class A Common Stock

Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.

The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.

Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value)

Ternium (TX) trades at $58.99, up 1.81% with strong Q2 2026 earnings beating estimates by 43%. The stock shows solid fundamentals with attractive valuation metrics including P/E of 16.39 and P/S of 0.72. Recent analyst upgrades to Strong Buy highlight improving sentiment as Mexico's steel recovery drives operational momentum and the $4B Pesqueria project promises future capacity growth.

The stock offers value with 7% dividend yield projections and 14.5% upside to $65.52 fair value. Key risks include steel price volatility and trade uncertainty, but declining CapEx should boost free cash flow above 15% yield. Analyst consensus at $57.17 with 50% Buy ratings supports cautious optimism for continued recovery.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MRVI
100% Buy0% Sell
Avg holding period · 0 Days
TX
100% Buy0% Sell
Avg holding period · 0 Days

About Maravai LifeSciences Holdings Inc. Class A Common Stock

Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.

Read more on MRVI →

About Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares USD1.00 par value)

Ternium S.A. is a Luxembourg-headquartered steel producer operating an integrated production system, from mining through finished flat and long steel products. It runs 18 production plants and two mining operations across Argentina, Brazil, Colombia, Guatemala, Mexico, and US, serving the automotive, construction, appliance, and energy industries.

Read more on TX →